首页> 外文期刊>Molecular pharmacology. >Determinants of 1-piperidinecarboxamide, N-(2-((5-amino-l-((4-(4-pyridinyl)-l-piperazinyl)carbonyl)pentyl)amino)-1- ((3,5-dibromo-4-hydroxyphenyl)methyl)-2-oxoethyl)-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-
【24h】

Determinants of 1-piperidinecarboxamide, N-(2-((5-amino-l-((4-(4-pyridinyl)-l-piperazinyl)carbonyl)pentyl)amino)-1- ((3,5-dibromo-4-hydroxyphenyl)methyl)-2-oxoethyl)-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-

机译:1-哌啶甲酰胺,N-(2-((5-氨基-1-((4-(4-吡啶基)-1-哌嗪基)羰基)戊基)氨基)-1-((3,5-二溴- (4-羟基苯基)甲基)-2-氧乙基)-4-(1,4-二氢-2-氧代-3(2 H)-喹唑啉基)(BIBN4096BS)对降钙素基因的亲和力

获取原文
获取原文并翻译 | 示例
           

摘要

1-Piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1- [(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS), a calcitonin gene-related peptide (CGRP) receptor antagonist, can alleviate the symptoms of migraine and is highly selective for CGRP over adrenomedullin (AM) receptors. These receptors are heterodimers of the calcitonin receptor-like receptor (CL) and receptor activity modifying proteins (RAMPs), with the pharmacological properties determined by the RAMP subunit. BIBN4096BS-sensitive CGRP(1) receptors are CL/RAMP1, whereas BIBN4096BS-insensitive AM receptors are CL/RAMP2 or CL/RAMP3 (AM(1) and AM(2), respectively), implicating RAMP1 in conferring BIB-N4096BS sensitivity. Because calcitonin receptors [CT((a))] also interact with RAMP1 [AMY(1(a)) receptors], BIBN4096BS could also have affinity for these receptors. To test this, receptors were transfected into COS-7 cells and agonist-stimulated cAMP levels measured in the presence and absence of antagonists. We found that AMY(1(a)) receptors were approximately 150-fold less sensitive to BIBN4096BS antagonism than CGRP(1) receptors. In contrast, AMY(3(a)) [CT((a))/RAMP3] or AM(2) receptors were not sensitive to BIBN4096BS antagonism. We investigated Trp74 in RAMP1, a residue implicated in the species selectivity of BIBN4096BS. BIBN4096BS affinity was reduced at AMY(1(a)) and CGRP(1) receptors when this residue was mutated to lysine or alanine. The equivalent residue in RAMP3, Glu74, when mutated to tryptophan (E74W), induced BIBN4096BS sensitivity at AM(2) and AMY(3(a)) receptors. It is interesting that a selective reduction in AM potency was observed at E74W AM(2) receptors, implicating this residue in AM interactions with this receptor. These data support the importance of Trp74 in RAMP1 in the interaction of BIBN4096BS with CGRP(1) and AMY(1(a)) receptors and identified Glu74 in RAMP3 as the first amino acid in RAMP important for agonist interactions with calcitonin-family receptors.
机译:1-哌啶甲酰胺,N- [2-[[5-氨基-1-[[4-(4-吡啶基)-1-哌嗪基]羰基]戊基]氨基] -1-[(3,5-二溴-4-降钙素基因相关肽(CGRP)受体拮抗剂,它可以缓解羟苯基]甲基] -2-氧代乙基] -4-(1,4-二氢-2-氧代-3(2 H)-喹唑啉基)(BIBN4096BS)偏头痛的症状,并且对CGRP的选择性高于肾上腺髓质素(AM)受体。这些受体是降钙素受体样受体(CL)和受体活性修饰蛋白(RAMP)的异二聚体,其药理特性由RAMP亚基决定。 BIBN4096BS敏感的CGRP(1)受体是CL / RAMP1,而BIBN4096BS不敏感的AM受体是CL / RAMP2或CL / RAMP3(分别是AM(1)和AM(2)),这暗示RAMP1赋予BIB-N4096BS敏感性。因为降钙素受体[CT((a))]也与RAMP1 [AMY(1(a))受体]相互作用,所以BIBN4096BS也可能对这些受体具有亲和力。为了测试这一点,将受体转染到COS-7细胞中,并在存在和不存在拮抗剂的情况下测量激动剂刺激的cAMP水平。我们发现,AMY(1(a))受体对BIBN4096BS拮抗作用的敏感性比CGRP(1)受体低150倍。相反,AMY(3(a))[CT((a))/ RAMP3]或AM(2)受体对BIBN4096BS拮抗作用不敏感。我们调查了RAMP1中的Trp74,这是一种与BIBN4096BS的物种选择性有关的残基。当此残基突变为赖氨酸或丙氨酸时,在AMY(1(a))和CGRP(1)受体处的BIBN4096BS亲和力降低。当突变为色氨酸(E74W)时,RAMP3中的等效残基Glu74诱导了AM(2)和AMY(3(a))受体的BIBN4096BS敏感性。有趣的是,在E74W AM(2)受体上观察到AM效能的选择性降低,暗示此残基参与了AM与该受体的相互作用。这些数据支持BIBN4096BS与CGRP(1)和AMY(1(a))受体相互作用中RAMP1中Trp74的重要性,并确定RAMP3中的Glu74是RAMP中的第一个氨基酸,对与降钙素家族受体的激动剂相互作用很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号